DPP9 and ovarian carcinoma: Patch et al. [10] showed that, in ovarian carcinomas, gene breakage was a common mechanism for inactivating tumor suppressor genes (RB1, NF1, RAD51B, and PTEN); thus, loss-of-function gene changes could explain the observed DPP9 downregulation.